Zika virus infection of first-trimester human placentas: utility of an explant model of replication to evaluate correlates of immune protection ex vivo

Curr Opin Virol. 2017 Dec:27:48-56. doi: 10.1016/j.coviro.2017.11.008.

Abstract

The emergence of congenital Zika virus (ZIKV) disease, with its devastating effects on the fetus, has prompted development of vaccines and examination of how ZIKV breaches the maternal-fetal barrier. Infection of placental and decidual tissue explants has demonstrated cell types at the uterine-placental interface susceptible to infection and suggests routes for transmission across the placenta and amniochorionic membrane. ZIKV replicates in proliferating Hofbauer cells within chorionic villi in placentas from severe congenital infection. Explants of anchoring villi recapitulate placental architecture and early-stage development and suggest infected Hofbauer cells disseminate virus to fetal blood vessels. ZIKV infection of explants represents a surrogate human model for evaluating protection against transmission by antibodies in vaccine recipients and passive immune formulations and novel therapeutics.

Publication types

  • Review

MeSH terms

  • Animals
  • Biological Assay / methods
  • Cell Proliferation
  • Female
  • Humans
  • Infectious Disease Transmission, Vertical
  • Organ Culture Techniques / methods
  • Placenta / virology*
  • Pregnancy
  • Pregnancy Trimester, First*
  • Viral Vaccines
  • Virus Cultivation / methods
  • Virus Diseases / virology
  • Virus Replication
  • Zika Virus / immunology*
  • Zika Virus / physiology
  • Zika Virus Infection / congenital
  • Zika Virus Infection / immunology*
  • Zika Virus Infection / transmission

Substances

  • Viral Vaccines